申请人:Burgdorf Lars Thore
公开号:US20100216794A1
公开(公告)日:2010-08-26
Novel heterocyclic compounds of the formula I
in which R
1
, R
2
, R
3
, R
4
and D have the meanings indicated in claim
1
, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
式I中的新型杂环化合物,其中R1、R2、R3、R4和D的含义如权利要求1所示,是葡萄糖激酶的激活剂,可用于预防和/或治疗1型和2型糖尿病、肥胖症、神经病和/或肾病。